Fluvoxamine
Fluvoxamine is a pharmaceutical drug with 50 clinical trials. Currently 3 active trials ongoing. Historical success rate of 94.6%.
Success Metrics
Based on 35 completed trials
Phase Distribution
Phase Distribution
19
Early Stage
7
Mid Stage
15
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
92.1%
35 of 38 finished
7.9%
3 ended early
3
trials recruiting
50
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19
Fluvoxamine for Long COVID-19
Clinical Trials (50)
Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19
Fluvoxamine for Long COVID-19
ACTIV-6: COVID-19 Study of Repurposed Medications
To Determine the Effect of KP-001 on Rosuvastatin, Caffeine PK and the Effect of Fluvoxamine on KP-001 PK in Volunteers
Pragmatic Trial of Obsessive-compulsive Disorder
Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)
Influence of Fluvoxamine on the Pharmacokinetics of BI 409306
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)
A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male Subjects
Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment
Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant
Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2)
Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients
Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients
A Clinical Trial of Fluvoxamine for Melancholia
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 50